Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypass
- 31 October 1994
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 58 (4) , 1036-1039
- https://doi.org/10.1016/0003-4975(94)90450-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Rapid recovery of platelet function after cardiopulmonary bypass [letter]Blood, 1993
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992
- Platelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1992
- Aspirin, blood loss, and transfusionThe Annals of Thoracic Surgery, 1990
- Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirementsThe Annals of Thoracic Surgery, 1990
- A Critical Reappraisal of the Bleeding Time*Seminars in Thrombosis and Hemostasis, 1990
- In vitro bleeding test - a simple method for the detection of aspirin effects on platelet functionThrombosis Research, 1989
- Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.Circulation, 1988
- PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASSThe Lancet, 1988
- Preoperative Aspirin Ingestion Increases Operative Blood Loss after Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 1988